Loading clinical trials...
Loading clinical trials...
In this study we want to investigate if combination therapy with rituximab (R) + dexamethasone (DXM) is superior to monotherapy with DXM in patients with newly diagnosed idiopathic thrombocytopenic pu...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Copenhagen University Hospital at Herlev
NCT06757257 · Chronic Idiopathic Thrombocytopenic Purpura
NCT04014413 · Crohn Disease, Ulcerative Colitis, and more
NCT05757570 · Immune Thrombocytopenia, Idiopathic Thrombocytopenic Purpura, and more
NCT05220878 · Idiopathic Thrombocytopenic Purpura
NCT00508820 · Idiopathic Thrombocytopenic Purpura, Thrombocytopenia, and more
Aalborg Hospital
Aalborg
Copenhagen University Hospital Rigshospitalet
Copenhagen
Esbjerg Hospital
Esbjerg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions